Lactose (India) Limited announces record date for share allotment under amalgamation
Lactose (India) · Pharmaceuticals & Biotechnology
Key highlights
- NCLT approved Scheme of Amalgamation between Vitanosh Ingredients Private Limited and Lactose (India) Limited on August 5, 2026
- Board meeting held on October 21, 2026 fixed November 2, 2026 as Record Date for equity shareholders of Vitanosh Ingredients
- Share exchange ratio fixed at 0.7946 equity shares of Lactose (India) Limited for every 1 equity share of Vitanosh Ingredients
Why it's rated notable: The filing fixes a record date for allotting Lactose (India) shares under an NCLT-approved amalgamation with Vitanosh Ingredients Private Limited, but states no value for the transaction, so the level stays at medium.
Original filing
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday, October 21, 2026 For Fixation Of Record Date
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Fine Organic Industries Ltd announces Q2 and H1 FY27 financial results and acquisitions
- Lloyds Metals and Energy Limited announces Q2 FY 2026-27 results and approves investments
- Kotak Mahindra Bank receives CCI approval for Deutsche Bank India business acquisition
- Endurance Technologies reports Q2 and H1 FY27 financial results with growth
- Prestige Estates Projects acquires 100% of Gloind Vintage Infra via PRVL
- Systematic Industries approves half-year results and allots 14,57,400 preferential shares
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.